Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP468466.RA_rRRt8O9sN5WXLE-Egl8a_m0u6gBbXbQM8Bf5umn8Y4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP468466.RA_rRRt8O9sN5WXLE-Egl8a_m0u6gBbXbQM8Bf5umn8Y4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP468466.RA_rRRt8O9sN5WXLE-Egl8a_m0u6gBbXbQM8Bf5umn8Y4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP468466.RA_rRRt8O9sN5WXLE-Egl8a_m0u6gBbXbQM8Bf5umn8Y4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP468466.RA_rRRt8O9sN5WXLE-Egl8a_m0u6gBbXbQM8Bf5umn8Y4130_provenance.
- NP468466.RA_rRRt8O9sN5WXLE-Egl8a_m0u6gBbXbQM8Bf5umn8Y4130_assertion wasGeneratedBy ECO_0000203 NP468466.RA_rRRt8O9sN5WXLE-Egl8a_m0u6gBbXbQM8Bf5umn8Y4130_provenance.
- NP468466.RA_rRRt8O9sN5WXLE-Egl8a_m0u6gBbXbQM8Bf5umn8Y4130_assertion wasDerivedFrom befree-20150227 NP468466.RA_rRRt8O9sN5WXLE-Egl8a_m0u6gBbXbQM8Bf5umn8Y4130_provenance.
- NP468466.RA_rRRt8O9sN5WXLE-Egl8a_m0u6gBbXbQM8Bf5umn8Y4130_assertion SIO_000772 22012255 NP468466.RA_rRRt8O9sN5WXLE-Egl8a_m0u6gBbXbQM8Bf5umn8Y4130_provenance.
- NP468466.RA_rRRt8O9sN5WXLE-Egl8a_m0u6gBbXbQM8Bf5umn8Y4130_assertion evidence source_evidence_literature NP468466.RA_rRRt8O9sN5WXLE-Egl8a_m0u6gBbXbQM8Bf5umn8Y4130_provenance.
- NP468466.RA_rRRt8O9sN5WXLE-Egl8a_m0u6gBbXbQM8Bf5umn8Y4130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468466.RA_rRRt8O9sN5WXLE-Egl8a_m0u6gBbXbQM8Bf5umn8Y4130_provenance.